AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies @CNBC *****AxDIW2XxtT
— Achilles (@AchillesofHomer) October 21, 2020
- AstraZeneca shares turned negative after a Brazilian health authority said a volunteer in its coronavirus vaccine study died.
- The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.
- The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States.